Cargando…
Identifying patients with metformin associated lactic acidosis in the emergency department
Background Metformin associated lactic acidosis (MALA) is a serious adverse event with a high mortality rate of 30–50%. Early recognition of MALA and timely starting treatment may reduce its morbidity and mortality. Objective The aim of this study was to explore clinical parameters to identify patie...
Autores principales: | van Berlo-van de Laar, I. R. F., Gedik, A., van ‘t Riet, E., de Meijer, A., Taxis, K., Jansman, F. G. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522070/ https://www.ncbi.nlm.nih.gov/pubmed/32960426 http://dx.doi.org/10.1007/s11096-020-01069-2 |
Ejemplares similares
-
Extracorporeal treatment of metforminassociated lactic acidosis in clinical practice: a retrospective cohort study
por: van Berlo-van de Laar, Inge R.F., et al.
Publicado: (2020) -
Metformin-Associated Lactic Acidosis
por: Suh, Sunghwan
Publicado: (2015) -
Binding interactions with sevelamer and polystyrene sulfonate in vitro
por: van Berlo‐van de Laar, Inge R.F., et al.
Publicado: (2021) -
Metformin-associated lactic acidosis: risk factors and prognostic factors
por: Falco, V Di, et al.
Publicado: (2013) -
Metformin-associated Lactic Acidosis: An Unexpected Scenario
por: Asif, Samia, et al.
Publicado: (2019)